Physician profile
Consetta Cheatam
NPI 1619989860
$720.80
in general payments reported to CMS, 2019-2025
18 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.09 · 2020: $92.41 · 2021: $27.01 · 2022: $68.08 · 2023: $164 · 2024: $132 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369 · Education: $71.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.51 |
| Education | $71.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $120.97 | 2020-2023 | Lo Loestrin Fe, Orilissa |
| Agile Therapeutics, INC. | $76.76 | 2022-2024 | Twirla |
| Organon LLC | $73.86 | 2024-2025 | Nexplanon |
| Millicent US INC | $71.70 | 2024-2025 | |
| Exeltis, USA INC. | $66.94 | 2024-2025 | Slynd |
| Lupin INC. | $55.47 | 2019-2020 | |
| Coopersurgical, INC. | $53.51 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $34.03 | 2023 | |
| Mission Pharmacal Company | $29.07 | 2019-2020 | |
| Meditrina | $21.25 | 2023 | |
| Medtronic, INC. | $19.19 | 2025 | Truclear |
| Astellas Pharma US INC | $17.52 | 2023 | Veozah |
| Mayne Pharma Commercial LLC | $16.10 | 2025 | |
| Evofem Biosciences, INC. | $13.46 | 2021 | |
| Avion Pharmaceuticals | $13.10 | 2023 | Balcoltra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.94 | 2019 | |
| Roche Diagnostics Corporation | $12.47 | 2020 | |
| Minerva Surgical, INC | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Consetta Cheatam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.